# Encapsulated Control: Shaping Insulin Fibrillation through Polymer Confinement

## TL;DR

This study explores how encapsulating insulin in polymer nanoparticles affects its structure and behavior at high temperatures.

## Contribution

The paper reveals distinct fibrillation pathways for free and encapsulated insulin due to differences in oligomeric states.

## Key findings

- Encapsulated insulin retains its secondary structure but shows altered pH sensitivity.
- Insulin in nanoparticles unfolds at lower temperatures compared to bulk insulin.
- Fibrillation pathways differ between free and encapsulated insulin due to oligomeric state changes.

## Abstract

The understanding of insulin conformational changes trapped
inside
a polymeric capsule is obscure, especially at elevated temperatures
above 40 °C. We studied the conformational changes of insulin
in bulk solution and upon encapsulation into polymeric self-assemblies
formed by poly­(ethylene oxide)-block-poly­(N,N,N-trimethylammonioethyl
methacrylate) copolymer that is oppositely charged to the protein.
We demonstrated that loading insulin into the nanoparticles does not
affect its secondary structure but alters the pH sensitivity of insulin,
making it more resistant to pH variation in the presence of the polymer.
However, the temperature resistance of insulin is weakened in the
environment of polyelectrolyte, which causes a lowering of the unfolding
temperature, and the conformational changes begin already at 40 °C
in the nanoparticle core. For the first time, we report that insulin
fibrillation follows distinct pathways in free and encapsulated forms,
a difference driven by insulin oligomeric state (hexamer in bulk and
trimer within the polyelectrolyte/insulin complex).